China crystal meth makers used GSK cold medicine: report

January 7, 2014

Some crystal methamphetamine seized in a huge drug bust in China used the popular cold medicine Contac, manufactured by beleaguered British drugmaker GlaxoSmithKline (GSK), state media reported Tuesday.

The raid in the southern province of Guangdong, announced by state media last week, netted three tonnes of "crystal meth" in Lufeng city, said to account for one-third of China's production of the drug.

Some makers extracted pseudoephedrine from Contac, even employing students to empty the powder from the capsules as part of the process, the Global Times newspaper reported.

Chinese authorities have already put GSK under scrutiny over an alleged bribery case, detaining four executives of the British company last year.

GSK did not confirm the media report, but said it was concerned about any illegal use of its medicines.

"As a responsible manufacturer, GSK is very concerned about any criminal activities which divert the use of our medicines for illicit purposes, and (we) vow to work with the appropriate authorities to ensure that we play our part in eradicating this criminal activity," it said in a statement provided to AFP.

Regulations require customers' names and identity card numbers to be registered before they can buy the medicine, sold under the name Contac NT in China, and put limits on the amount that can be purchased, the statement said. A higher strength form requires a doctor's prescription.

Paramilitary troops and police officers used helicopters and speedboats in the drug raids, which also saw 23 tonnes of raw materials seized and nearly 200 suspects from 18 drug rings arrested, the official Xinhua news agency has reported.

Methamphetamine is the second most popular in China after heroin, according to a report last year by the United Nations Office on Drugs and Crime (UNODC).

Explore further: Chinese police say Glaxo employees bribed doctors

Related Stories

Chinese police say Glaxo employees bribed doctors

July 11, 2013

China's police ministry accused executives of pharmaceutical supplier GlaxoSmithKline on Thursday of conducting a large and long-running bribery campaign to persuade doctors to prescribe drugs.

China launches crackdown on drug industry

July 17, 2013

(AP)—China announced a crackdown Wednesday on misconduct in its drug market, stepping up pressure on the problem-prone industry while it pursues a bribery investigation of GlaxoSmithKline.

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.